Previous Article | Next Article 
Molecular and Cellular Biology, October 2000, p. 7706-7715, Vol. 20, No. 20
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
No Obvious Abnormality in Mice Deficient in
Receptor Protein Tyrosine Phosphatase
S.
Harroch,1
M.
Palmeri,1
J.
Rosenbluth,2
A.
Custer,3
M.
Okigaki,1
P.
Shrager,3
M.
Blum,4
J. D.
Buxbaum,5 and
J.
Schlessinger1,*
Department of Pharmacology and the Skirball
Institute1 and Department of Physiology
and Neuroscience,2 New York University Medical
Center, New York, New York 10016; Department of Neurobiology
and Anatomy, University of Rochester Medical Center, Rochester, New
York 146423; and Departments of
Neurobiology4 and
Psychiatry,5 Mount Sinai School of
Medicine, New York, New York 10029
Received 27 April 2000/Returned for modification 30 June
2000/Accepted 12 July 2000
 |
ABSTRACT |
The development of neurons and glia is governed by a multitude of
extracellular signals that control protein tyrosine phosphorylation, a
process regulated by the action of protein tyrosine kinases and protein
tyrosine phosphatases (PTPs). Receptor PTP
(RPTP
; also known as
PTP
) is expressed predominantly in the nervous system and exhibits
structural features common to cell adhesion proteins, suggesting that
this phosphatase participates in cell-cell communication. It has been
proposed that the three isoforms of RPTP
play a role in regulation
of neuronal migration, neurite outgrowth, and gliogenesis. To
investigate the biological functions of this PTP, we have generated
mice deficient in RPTP
. RPTP
-deficient mice are viable, are
fertile, and showed no gross anatomical alterations in the nervous
system or other organs. In contrast to results of in vitro experiments,
our study demonstrates that RPTP
is not essential for neurite
outgrowth and node formation in mice. The ultrastructure of nerves of
the central nervous system in RPTP
-deficient mice suggests a
fragility of myelin. However, conduction velocity was not altered in
RPTP
-deficient mice. The normal development of neurons and glia in
RPTP
-deficient mice demonstrates that RPTP
function is not
necessary for these processes in vivo or that loss of RPTP
can be
compensated for by other PTPs expressed in the nervous system.
 |
INTRODUCTION |
Protein tyrosine phosphatases
(PTPs), in concert with protein tyrosine kinases (PTKs), regulate
signal transduction pathways by tyrosine phosphorylation and
dephosphorylation. PTPs comprise a structurally diverse family of
enzymes. One group of PTPs exhibit structural features that are also
common to cell surface receptors and cell adhesion molecules (CAMs),
suggesting that these receptors may play a role in cell-cell
communication (4, 43). These receptor-like PTPs (RPTPs) are
composed of an extracellular domain, a single transmembrane domain, and
a cytoplasmic portion that contains one or two tyrosine phosphatase
domains. RPTP
(also known as PTP
) and RPTP
are two members of
a subfamily of RPTPs that contain a region in their extracellular
domains that has sequence homology to the enzyme carbonic anhydrase
(CAH) (2, 3, 24, 25). In both RPTP
and RPTP
, the CAH
domain is followed by a fibronectin domain type III repeat and by a
long unique sequence termed the spacer domain. Three different isoforms of RPTP
are expressed as a result of alternative mRNA splicing: a
short and a long form that differ by the presence of a stretch of 860 amino acid residues in the spacer domain and a secreted form composed
of only the extracellular domain of RPTP
, also known as 3F8
proteoglycan or phosphacan. Both transmembrane RPTP
s and the
phosphacan isoform are predominantly expressed as chondroitin sulfate proteoglycans.
Previous studies have suggested a role for RPTP
in gliogenesis and
neuron-glial cell interaction, neurite outgrowth, and neuronal
migration, as well as in regeneration after injury (21, 26,
43).
RPTP
is expressed predominantly by glial cells, astroglia,
oligodendrocytes, and Schwann cells but also by neurons throughout the
developing and adult nervous system (5, 41). Both
transmembrane forms of RPTP
are predominantly expressed in glial
progenitors cells located in the ventricular and subventricular zone,
where active cell proliferation occurs. Phosphacan is expressed at high levels by more mature glial cells, which suggests that the expression of RPTP
is regulated during glial cell differentiation
(6). Furthermore, RPTP
expressed at the surface of glial
cells binds to a cell recognition complex on neurons consisting of
several proteins which include contactin, Caspr (also named paranodin) (34, 35), and Nr-CAM (40). On the basis of the
localization of Caspr at the paranode, it was suggested that RPTP
is
involved in myelination and formation of the node (10).
RPTP
has been shown to bind to a variety of CAMs and matrix
components such as tenascin (18), Nr-CAM (40),
L1, contactin (34), and pleiotrophin (28).
Overlapping localization of phosphacan and most of the binding proteins
is observed in the central nervous system (CNS), suggesting that these
interactions could occur in vivo and may be involved in the control of
cell proliferation, migration, adhesion, neurite outgrowth, and
pathfinding in the brain. It was shown that chondroitin sulfate
proteoglycans and CAM are often upregulated during brain damage or
nerve injury (12, 30). Furthermore, it was demonstrated that
RPTP
is upregulated after sciatic nerve crushes, suggesting a role
of RPTP
in regeneration after injury (26).
The three isoforms of RPTP
are expressed throughout the developing
and adult nervous system. Interestingly, phosphacan binds to neurons
and inhibits adhesion and neurite outgrowth (13, 17). In
contrast, the extracellular portion of RPTP
has been shown to induce
neurite outgrowth. RPTP
induces neurite outgrowth through its
interaction with contactin and Nr-CAM (40). In addition, phosphacan can also stimulate neurite outgrowth of mesencephalic and
hippocampal neurons (11). It was demonstrated that
heterophilic interaction between RPTP
and pleiotrophin mediates cell
migration of cortical neurons, a process blocked by the PTP inhibitor
sodium vanadate (28). Moreover, it has been shown that
mesencephalic dopaminergic (DA) neurons express phosphacan. A
heterophilic interaction between phosphacan on the neurons and L1 on
the fibers may be involved in the control of migration of mesencephalic
DA neurons (33), suggesting that RPTP
may play a more
general role in cell migration.
To explore the biological function of RPTP
in vivo, we have
generated mice deficient in the three isoforms of RPTP
. These RPTP
/
mice are viable and fertile and showed no
gross anatomical alterations. We have tested the importance of RPTP
in myelination, neurite outgrowth, and node formation in the adult
mouse. Our results demonstrate that RPTP
is not required for neurite
outgrowth and paranode formation, in contrast to what has been proposed
based on in vitro experiments. However, ultrastructure of the CNS
nerves suggests a fragility of the myelin but with no alteration of
conduction velocity.
 |
MATERIALS AND METHODS |
RPTP
targeting vector.
A genomic clone containing one
part of the CAH domain of the RPTP
gene was isolated from a
FIXII
mouse genomic library (129SV/Ev strain; Stratagene) by hybridization
with a rat cDNA fragment corresponding to the CAH domain. A targeting
vector was designed to contain 4.1 kb of 5' homologous sequence, a
pgk-neo cassette (42) replacing one exon in the
opposite direction to RPTP
gene transcription, 2.1 kb of 3'
homologous sequence, and the herpes simplex virus (HSV) thymidine
kinase gene (tk). Embryonic stem (ES) cells were grown on
mitomycin C-treated primary embryonic fibroblasts that had been
extracted from day 15 embryos at 37°C in Dulbecco's modified
Eagle's medium supplemented with 15% heat-inactivated fetal bovine
serum (HyClone), 0.1 mM 2 mercaptoethanol, 1 mM sodium pyruvate, and
103 U of leukemia inhibitory factor (GIBCO) per ml. Cells
(7 × 106) were electroporated in 800 µl of
phosphate-buffered saline (PBS) with 32 µg of
NotI-linearized targeting vector DNA at 240 V and 500 mF
using a gene pulser (Bio-Rad) and plated on gelatin-coated plastic
dishes. After 48 h, the cells were transferred to growth medium
supplemented with G418 (150 µg/ml; GIBCO) and ganciclovir (2 µg/ml;
Syntex). ES cell clones were screened by PCR using the enzyme Expand
(Boehringer) and oligonucleotides located in the neo gene
and in RPTP
gene. Positive clones were then confirmed by Southern
blot analysis. To accomplish this, genomic DNA was digested with
EcoRI, transferred onto nylon filters, and hybridized with a
radioactively labeled PstI fragment from the original phage clone (Fig. 1). Three independent
targeted ES clones were used in embryo aggregation experiments for
generation of mice. Chimeric mice were crossed to Swiss Webster mice.
Heterozygous and homozygous animals were identified by PCR and Southern
blot analysis.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
RPTP gene organization and structure of the disrupted
RPTP gene. (A) Restriction map of the mouse RPTP gene. Translated
exons are represented by closed boxes and numbered I to III. E, B, H,
P, RV, S, and X represent cleavage sites for EcoRI,
BamHI, HindIII, PstI,
EcoRV, SacI, and XbaI (not all sites
given), respectively. WT, wild type. (B) Restriction map of the
RPTP -targeting construct p5'PGKneo3'TK, containing 4 and 2.1 kb of
homologous sequences on the 5' and 3' sites of the neo
insertion, respectively. pgk-neo and HSV tk
cassettes are indicated by boxes. Arrows indicate transcriptional
orientation of the genes. N represents cleavage site for
NotI. (C) Structure of the RPTP gene after homologous
recombination and localization of probes. Horizontal bars indicate the
localization of 5' and 3' hybridization probes. Small arrows represent
the position of the oligonucleotide used for PCR analysis.
|
|
RNA preparation and Northern blot analysis.
Total RNAs from
brains of RPTP
+/+, RPTP
+/
, and
RPTP
/
mice were isolated by the guanidine
thiocyanate method (7). RNA were electrophoresed in a 1%
agarose gel containing 7% formaldehyde and transferred to a nylon
membrane (Schleicher & Schuell). Hybridization was performed with a
radiolabeled 500-bp mouse cDNA probe coding for the CAH domain in 0.25 M sodium phosphate buffer (pH 7.4)-7% sodium dodecyl sulfate,
followed by autoradiography.
Primary antibodies.
Rabbit polyclonal antibody against
CasprI was a gift from E. Peles and used at a dilution of 1:5,000;
rabbit polyclonal antibody against ankyrinG, a gift from S. Lux, was used at a dilution of 1:500. Mouse monoclonal antibody against
the sodium channel (previously characterized by Rasband et al.
[37]) was used at a dilution of 1:10,000. Rabbit
anti-rat tyrosine hydroxylase (TH) polyclonal antibody (Pel-Freeze) was
used at 1:1,000.
TH staining.
Mice were anesthetized and transcardially
perfused with ice-cold saline followed by perfusion with 4%
paraformaldehyde (PFA) in 0.1 M phosphate buffer, pH 7.4 (PB). The
brains were removed, cut into 3- to 4-mm blocks containing the
midbrain, and postfixed in 4% PFA for 5 h. Subsequently, the
brain blocks were placed in cold 30% sucrose in 0.1 M PB overnight,
and 40-µm vibratome sections were cut. Using a random start, a 1:8
series of sections was collected for TH immunocytochemistry.
Free-floating sections were incubated overnight at 4°C with a rabbit
anti rat-TH polyclonal antibody (Pel-Freeze) (1:1,000 in PBS-3% goat
serum-0.3% Triton X-100). After removal of the primary antibody and a
wash with PBS, the sections were incubated for 2 h at room
temperature with anti-rabbit immunoglobulin G conjugated with biotin
(Amersham) (1:200 in PBS-3% goat serum-0.3% Triton X-100). The
secondary antibody was removed, sections were washed, the reaction was
quenched for 5 min in 0.3% H2O2 in PBS, and
the samples were incubated with ExtraAvidin-peroxidase (1:200; Sigma)
for 1 h before being incubated with 3,3'-diaminobenzidine.
Light microscopy.
Mice were deeply anesthetized and perfused
through the left ventricle with 3% PFA in 0.1 M PB. Brains were
removed and postfixed in the same fixative overnight, washed in PB, and
embedded in paraffin. Sections of 6 µm were cut and stained with
cresyl violet. For Timm staining, mice were perfused through the left
ventricle with sodium sulfide solution (19) followed by 4%
PFA. Then 6-µm paraffin sections were mounted and stained in darkness
at 24°C as described elsewhere (19). After staining for 15 or 45 min, the sections were counterstained with cresyl, dehydrated,
and coverslipped.
Electron microscopy.
Mice were anesthetized with
pentobarbital and perfused transcardially with a fixative consisting of
3% glutaraldehyde and 2% PFA in 0.1 M cacodylate buffer (pH 7.3).
Optic nerve and spinal cord segments were dissected out, rinsed,
postfixed in 1 to 2% osmium tetroxide, with or without added 1.5%
potassium ferricyanide, in 0.1 M cacodylate buffer, dehydrated in a
graded series of alcohols, and embedded in Araldite or an Epon-Araldite
mixture. Sections of 1 µm were cut with glass knives and stained with
1% toluidine blue for survey by light microscopy. Selected areas were
then sectioned at ~0.1 µm, mounted on copper grids, stained with
potassium permanganate followed by ethanolic uranyl acetate, and
examined in a Philips 300 electron microscope. Both cross and
longitudinal sections were studied. Animals studied ranged in age from
2 to 9.5 months.
Suction electrode recording.
Mouse optic nerves were
dissected and placed in a recording chamber that was continuously
perfused and temperature regulated. The standard Locke's solution
contained NaCl (154 mM), KCl (5.6 mM), CaCl2 (2 mM),
D-glucose (5.6 mM), and HEPES (10 mM, pH 7.4). For
stimulation and recording of compound action potentials (CAPs), each
end of the nerve was drawn into a suction electrode. Stimuli consisted
of 50-µs pulses that were adjusted to 10% above the level required
for a maximal response. After a stimulus, CAPs were amplified,
digitized, recorded, and analyzed with a laboratory computer.
Conduction velocity was calculated as the length of the nerve divided
by the time to the first peak amplitude of the CAP. For some
experiments, CAPs were measured, and then nerves were fixed and used
for labeling experiments.
Immunocytochemistry.
Optic nerves were dissected, fixed in
4% PFA (pH 7.2) for 30 min, and soaked overnight in 20% sucrose at
4°C. The nerves were then frozen in OCT mounting medium (Miller), cut
into 10-µm sections on a microtome, and dried on gelatin-coated
coverslips. The sections were incubated in PBTGS (45 ml of 0.1 M PB,
150 µl of Triton X-100, 5 ml of goat serum) for 1 to 2 h to
permeabilize and block. All subsequent solutions used PBTGS for
dilutions or washing, and all incubations were done at room
temperature. Three washes of 5 min were done after each antibody
incubation. Rabbit polyclonal antibodies were applied first for 15 h. Anti-rabbit Alexa 488 (1:500; Molecular Probes, Eugene, Oreg.) was
then added for 1 h. For double labeling, mouse monoclonal
antibodies were added for 15 h, and anti-mouse Cy3 (1:500;
Accurate Chemicals, Westbury, N.Y.) was applied for 1 h. Sections
were then washed serially in PBTGS, 0.1 M PB, and 0.05 M PB and allowed
to air dry. The labeled sections were mounted on slides and viewed
under a Nikon Microphot-SA fluorescence microscope. Images were taken
by a C4742-95 cooled charge-coupled device camera (Hamamatsu)
controlled by Image Pro software (Media Cybernetics).
 |
RESULTS |
Generation of RPTP
-deficient mice.
Using a rat cDNA
fragment corresponding to the CAH domain of the RPTP
gene, a clone
including a 3' part of this domain was isolated from a mouse 129Sv/Ev
genomic library. The targeting vector for the RPTP
gene comprised
4.1 kb of 5' homologous sequence, a pgk-neo cassette in
opposite direction to RPTP
gene transcription (42)
replacing one exon, 2.1 kb of 3' homologous sequence, and HSV
tk for selection against random integration (29).
Homologous recombination with this targeting vector results in a loss
of exon 2 and in inadequate splicing, resulting in a null mutation.
After electroporation of the linearized targeting vector into either R1
or W4 ES cells followed by double selection with G418
and ganciclovir,
approximately 1 clone out of 100 or 1 clone out
of 50, respectively,
carried the desired mutation as determined
by PCR (data not shown) and
verified by Southern blot analysis
with the 3' external probe. The
presence of a new
EcoRI site introduced
by insertion of
neo sequence into RPTP

gene was detected by the
appearance of a 4.5-kb band in addition to the wild-type band
of 10
kb.
Chimeric mice were obtained after aggregation of targeted ES cells.
Chimeric males showed germ line transmission of the disrupted
RPTP

gene as analyzed by Southern blot analysis. Crossing of
heterozygous
RPTP

/+ offspring yielded homozygous RPTP

-deficient
mice with strictly
Mendelian frequencies. Southern blot analysis of
these mice with
3' and 5' external probes (Fig.
2A), as well as with a
neo probe,
showed the pattern expected for a single
integration by homologous
recombination (data not shown). We
subsequently used PCR with
a reverse oligonucleotide in the
neo promoter and a forward oligonucleotide
on the 3' arm or
in exon II to screen for homozygous animals (Fig.
1 and
2B).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 2.
Southern, PCR, Northern, and immunoblot analyses of
wild-type and RPTP -deficient mice. (A) Southern blot analysis. DNA
from wild-type, RPTP /+, and RPTP /
mice digested with EcoRI was hybridized with a 3' probe
(PstI probe). The 10-kb band represents the wild-type
allele, and the 4.5-kb band represents the mutant allele. (B) PCR
analyses. For easy screening, we used a PCR wherein the wild-type (WT)
allele is amplified as a 500-bp DNA and the mutant allele is amplified
as a 300-bp product. (C) Northern blot analysis. RNA from brains of
RPTP +/+, RPTP / , and
RPTP /+ mice was hybridized with a 500-bp cDNA fragment
encoding the mouse CAH domain. Arrows point to the three transcripts of
RPTP in both wild-type and heterozygous RNAs that are absent in
RPTP / mice. Sizes are indicated in kilobases.
|
|
To determine whether the mutated RPTP

gene is transcribed, total
RNAs from brains of RPTP

/
, RPTP

/+,
RPTP
+/+ mice were subjected to Northern blot analysis.
After hybridization
with a mouse cDNA specific probe for the CAH
domain, no hybridization
was detectable with RNA from RPTP

-deficient
mice, while RPTP
mRNAs of 9.5, 8.5, and 6.4 kb were clearly detected
in RPTP

/+ and RPTP
+/+ mice, indicating
that the mutated gene is not transcribed. All
forms of mRNA having been
lost, we therefore concluded that insertion
of the mutation into the
RPTP

gene generated mice lacking the
soluble form phosphacan as well
as the two transmembrane forms.
RPTP

/+ animals showed
similar amounts of RPTP

mRNAs and were therefore
used as
controls.
Morphological analysis of the CNS of RPTP
-deficient mice.
At the light microscopic level, the general morphology of brains of
2-month-old RPTP
/
mice appeared normal and
indistinguishable from that of wild-type littermates. Cross sections
through the hippocampi of RPTP
-deficient mice displayed a normal
pattern of migration of pyramidal cells in the dentate gyrus (Fig. 3A
and B). In addition, we found no abnormalities in the subventricular zones of RPTP
/
mice (data not shown). In the cerebella of 2-month-old
RPTP
-deficient mice, the molecular layer, Purkinje cell layer, and
internal granular cell layer appeared normal (Fig. 3C and D). Because
RPTP
is also expressed in cortical neurons (41), we also
compared the lamination and organization of the cortex. We chose to
look at the somatosensory cortex, where the layers are most
distinguishable. The number of cells and organization in the six layers
were apparently similar in wild-type and RPTP
-deficient mice (Fig.
3E and F), indicating that RPTP
is not necessary for cortical neuron
migration. To further investigate the cortex, we examined the
distribution of specific neuronal markers. Phosphacan is expressed by
interneurons in the cortex (20). The calcium-binding protein
parvalbumin and calbindin are expressed in distinct subpopulations of
neurons. We investigated the density of inhibitory interneurons by
immunocytochemistry using antibodies to the Ca2+-binding
protein parvalbumin as a marker for a subpopulation of GABAergic (gamma
amino butyric acid) neurons. The density of parvalbumin-immunoreactive cells did not differ between wild-type and mutant animals in this region (data not shown). Immunostaining with anticalbindin (data not
shown) revealed no difference in number, localization, or expression
pattern between RPTP
/
and control cortex samples.

View larger version (152K):
[in this window]
[in a new window]
|
FIG. 3.
Analysis of the hippocampi, cortices, and cerebella of
RPTP -deficient mice by light microscopy. Sections of 6 µm through
hippocampi (A and B), cerebella (C and D), and cortices (E and F) of
adult wild-type (A, C, and E) and RPTP -deficient (B, D, and F) mice
were stained with Nissl stain. The overall histology, number, and
localization of each cell type in these regions of the brain appear
normal in RPTP -deficient mice. ml, molecular layer; pl, Purkinge
cell layer; gl, internal granular layer; DG, dentate gyrus.
|
|
Various experiments in vitro have suggested a role of RPTP

in
neurite outgrowth. For example, RPTP

promotes neurite outgrowth
from
mesencephalic and hippocampal neurons (
8,
11). To test
this
hypothesis, we inspected the dentate gyrus of the hippocampus,
where
RPTP

is highly expressed, in relation to axonal projections,
the
mossy fibers (MFs). MFs are the axon of the neuron, which
form the
granule cell layer of the dentate gyrus. MF axons of
the dentate
granule cells establish synaptic contacts with neurons
in the dentate
hilus and with pyramidal cells of the hippocampal
CA3 (
1).
We used Timm's staining, which specifically reveals
MFs and their
synaptic expansion, to study MFs in RPTP

/
and
control mice. Timm's stain of wild-type and RPTP

/
hippocampus sections did not reveal reduced staining or an alteration
of the distribution of the fibers in RPTP

/
mice
(data not
shown).
Normal migration of mesencephalic neurons in
RPTP
/
mice.
Mesencephalic DA neurons, generated
in the ventricular zone of the mesencephalon, migrate first ventrally
from the ventricular surface along radial glial processes and then
laterally along tangentially arranged nerve fibers to their
destinations, the substantia nigra pars compacta, the reticular
formation, and the ventral tegmental area. The expression of phosphacan
by DA neurons and its interaction with L1 and Ng-CAM have implicated a
role for it in the lateral migration of DA neurons (33).
This study showed that the laterally migrating substantia nigra DA
neurons express phosphacan. Since the ventral tegmental DA neurons seem to migrate only radially, they may not require phosphacan for proper
migration. Thus, in the absence of phosphacan, we may observe all DA
neurons clustered in the ventral tegmental area, with an absence of DA
neurons in the substantia nigra. Migration of DA neurons was
histologically examined in RPTP
-deficient mice and control animals
by a series of sections through the midbrain stained with an antibody
directed against TH, a DA-synthesizing enzyme. As seen in Fig.
4, DA neurons migrate properly in
RPTP
-deficient mice.

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 4.
Localization of mesencephalic DA neurons. Coronal
sections of RPTP / and RPTP /+ adult
animals were stained with anti-TH antibodies, revealing mesencephalic
DA neurons. Wild-type and RPTP / DA neurons migrated
properly laterally and did not localize ventrally. SN, substantia
nigra.
|
|
Electron microscopy of optic nerves of RPTP
-deficient mice.
RPTP
is expressed by cells of the oligodendrocyte lineage during
development and in the adult (6). It has been suggested that
RPTP
is involved in formation of the node of Ranvier
(10). We evaluated myelination in 2-month-old brains stained
with luxol fast blue, a stain specific for myelin, and detected no
difference in staining between wild-type and RPTP
/
mice (data not shown).
We then analyzed the ultrastructure of myelin in the optic nerves of
animals at various ages. Myelin in the optic nerves and
spinal cords of
both old and adult RPTP

/
mice is grossly normal in
appearance (Fig.
5A and B) with respect
to periodicity and thickness. As in the wild-type animals, myelin
thickness in the RPTP

/
animals increases with fiber
diameter. The radial component is
present, and the inner and outer
mesaxons form tight junctions
(Fig.
5D). In comparison with wild-type
controls, however, there
is a greater tendency for fragmentation of the
RPTP

/
myelin (i.e., separation and disintegration of
lamellae), especially
in thicker sheaths (Fig.
5C), and for deformation
of the myelin
sheath profiles, resulting in redundant folds (Fig.
5C)
(
38).
In addition, in the myelin sheaths of
RPTP

/
animals, cytoplasm-containing lamellae can be
found extending
into juxtaparanodal regions (Fig.
6D) as well as in
internodal
myelin (Fig.
5C).

View larger version (200K):
[in this window]
[in a new window]
|
FIG. 5.
Ultrastructure of the optic nerve. (A) Survey view of
wild-type optic nerve cross section (magnification, ×12,600). The
myelin sheaths surrounding the larger axons appears more compact than
those in panel B. (B) Survey view of RPTP / optic
nerve cross section (×12,600). In the larger fibers, myelin lamellae
tend to separate. Extraneous whorls (arrow) of myelin are apposed to an
oligodendrocyte. (C) Large fiber from RPTP / optic
nerve (×31,500). The sheath appears somewhat raveled (black arrows)
and in one region the lamellae contain cytoplasm (white arrow). Just
above, two (large 1 and 2) fibers are surrounded by sheaths that form
redundant folds (small numbers). (D) Small fiber from
RPTP / optic nerve (×182,000). Both inner and outer
mesaxons form tight junctions. Radial component (arrows) is visible in
one quadrant of the sheath.
|
|
Nodal and paranodal areas in the RPTP

/
animals also
appear grossly normal. The nodal gap approximates 1 µm, and the nodal
axolemma displays a typical undercoating (Fig.
6B). Paranodal
loops
form junctions with the axolemma. The junctional cleft is
~2 nm wide
and contains transverse bands, the periodic dense ridges
that extend
between the membranes of the paranodal axolemma and
the glial loops
(Fig.
6C). In small fibers, the
overlapping pattern
of the terminal loops displays the normal
arrangement, i.e., with
the outermost loops closest to the node and
ending against the
axolemma (Fig.
6B). In more heavily myelinated
fibers of both
wild-type (Fig.
6A) and RPTP

/
(Fig.
6C) animals, some of the terminal loops end either on other
loops or in
an everted pattern facing away from the axolemma.

View larger version (151K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of the node and paranode by electron
microscopy. (A) Paranodal junction from a wild-type spinal cord
(magnification, ×100,000). Some terminal loops adjoin the axolemma and
form junctions containing transverse bands (arrowheads); others do not
reach the axolemma. The node of Ranvier (n) is at the right. The axon
(ax), paranode (pn), and myelin sheath (m) are indicated. (B) Small
fiber from RPTP / optic nerve (×79,000). The node of
Ranvier (right) shows undercoated plasma membrane (arrow). Myelin
lamellae form a regular succession of overlapping terminal loops. (C)
Detail of paranodal junction from a large fiber in
RPTP / spinal cord (×152,000). Some terminal loops
end against the axolemma, forming junctions containing periodic
transverse bands. Not all terminal loops reach the axolemma, however.
(D) Paranodal (pn) and juxtaparanodal (in) regions of axon in a large
fiber from RPTP / spinal cord (×87,500).
Cytoplasm-containing lamellae extend beyond the paranode toward the
internode (arrows).
|
|
Na2+ channel clustering, Caspr localization, and
conduction velocity of the optic nerve.
Recent studies suggested
that RPTP
might mediate interactions between axons and glial cells
(35) through interaction with the contactin-Caspr complex.
Caspr is a membrane protein highly expressed in the CNS that copurified
with contactin when the CAH of RPTP
was used as an affinity probe.
It was shown that Caspr is an essential component of the paranode
(10). Thus, RPTP
could play a role in formation of the
paranode and node of Ranvier. We therefore analyzed optic nerve
sections, labeled for voltage-gated sodium channels to mark nodes of
Ranvier and labeled for CasprI to mark paranodes (Fig.
7A). Both the nodes of Ranvier and
paranodes in RPTP
/
mice exhibited normal morphology
and showed similar fluorescence staining with antibody markers compared
with control animals (Fig. 7A). Optic nerve sections were also labeled
for ankyrinG, a protein that links sodium channels to the
cytoskeleton and is also located in the nodes of Ranvier
(23). No differences in morphology or fluorescence intensity
were seen with this label either. No difference was apparent in the
number of labeled sites between RPTP
/
and control
animals with any of the antibodies used (Fig. 7A).


View larger version (44K):
[in this window]
[in a new window]
|
FIG. 7.
Localization of Na2+ channels and Caspr in
the optic nerve and conduction velocity measurements. Normal nodes and
paranodes are found in optic nerves of RPTP / mice.
(A) Optic nerve sections were labeled with antibodies specific for
sodium channels (red), Caspr (green), and ankyrinG. No
apparent differences in labeling were seen between nerves from
wild-type and RPTP / mice (scale bars = 10 µm). (B) Conduction velocity measurements of nerves from wild-type
and RPTP / mice at 25°C (P = 0.85)
or 37°C (P = 0.38). Results represent mean ± standard deviation of four nerves.
|
|
Despite the normal clustering of Na
2+ channels and Caspr
localization in the optic nerves of RPTP

-deficient mice, functional
changes could result from the alteration in myelin structure that
have been detected in the optic nerves of RPTP

-deficient mice.
To
investigate the electrophysiological properties of CNS axons
in
RPTP

-deficient mice, the CAPs of RPTP

/
optic
nerves was recorded using suction electrodes, and conduction
velocity
was calculated using the fastest component of the CAP.
Measurement of
the conduction velocity at 25°C revealed no significant
difference
between RPTP

/
and normal nerves (Fig.
7B). While the
conduction velocity of
RPTP

/
nerves appeared to be
somewhat slower than for controls at 37°C,
this difference is not
statistically significant (
P = 0.377).
The shape of
CAPs in RPTP

/
nerves was similar to that seen in
control
nerves.
 |
DISCUSSION |
The mutation introduced in the RPTP
gene abolishes
expression of the three isoforms of RPTP
, the two transmembrane
isoforms and the soluble isoform (phosphacan), since we have abolished transcription of the RPTP
gene. Nevertheless, the RPTP
-deficient mice described in this study are normal in their gross general behavior
and with respect to fertility, body weight, and life span.
The gross anatomy of the brain and spinal cord and the morphology of
the cerebellum of RPTP
-deficient mice do not show any alteration at
the light microscopy level compared to their littermate controls. We
could not detect aberrant localization of cells that normally express
RPTP
in the cerebellum, hippocampus, or cerebral cortex. Therefore,
RPTP
appears not to be necessary for the migration of these neural
cell types to their correct locations in these areas of the CNS.
RPTP
and RPTP
belong to the same subfamily of RPTPs. Surprised by
the lack of obvious phenotype in RPTP
-deficient mice, we tested
whether the expression of RPTP
is altered in RPTP
-deficient mice
to compensate for RPTP
deficiency. The expression of RPTP
is
restricted to the nervous system, while RPTP
is ubiquitously expressed. However, certain neurons, especially cortical and
hippocampal neurons, express both RPTP
and RPTP
. Northern blot
analysis of mRNA prepared from adult RPTP
/
,
RPTP
/+, or RPTP
+/+ brain mRNA showed no
alteration of transcription of the RPTP
gene, indicating that
RPTP
is not altered in RPTP
/
mice (data not
shown). However, we cannot rule out the possibility that RPTP
function in RPTP
/
mice is compensated for by another
tyrosine phosphatase.
Evidence from in vitro studies suggests that RPTP
family members
play a key role in neuronal migration, neurite outgrowth, and cell
adhesion. The secreted form of RPTP
, phosphacan, is a chondroitin
sulfate, highly expressed in the brain. Phosphacan inhibits nerve
growth factor-induced neurite outgrowth of PC12D in culture
(22) and neurite outgrowth of dorsal root ganglia explants
(14). In contrast, phosphacan promotes neurite outgrowth from mesencephalic and hippocampal neurons (8). We tested
whether dorsal root ganglia prepared from day 15 embryo
RPTP
/
or control samples and cultured for 2 weeks
showed any changes in neurite length, but we did not detect any obvious
difference (data not shown). We have also shown that the cells of the
dentate gyrus, where RPTP
is highly expressed, are able to produce
normal MFs, as revealed by Timm and calbindin staining. Finally, we
found no obvious difference in neurite length in mesencephalic neurons demonstrating, that in vivo, RPTP
is not necessary for neurite growth.
RPTP
isoforms are found in the developing nervous system, in
patterns suggesting the involvement of these enzymes in neuronal migration and axonal guidance. RPTP
was implicated in the
differentiation of cortical neurons (27), the migration of
olfactory neurons (32), and the migration of mesencephalic
DA neurons (33). In the cortex, RPTP
is expressed in
layers II, III, and IV (41), and phosphacan has been found
also in layers II, IV, and VI (20). Nissl stain- as well as
calbindin- or parvalbumin-immunoreactive cells exhibited no difference
with respect to number and localization in RPTP
-deficient mice
compared to control mice. We have also demonstrated that mesencephalic
DA neurons migrate to their final destination in RPTP
-deficient
mice, suggesting that RPTP
does not play a major role in neuronal
migration. Of course, RPTP
could regulate the migration of a
particular subset of neurons that were not detected. However,
phosphacan is expressed in most parvalbumin-positive cells
(20), neurons that were well localized in RPTP
-deficient mice.
RPTP
and myelination.
Previous studies suggest that RPTP
could be involved in the formation of the paranode. RPTP
, contactin,
and Caspr/paranodin form a complex (35) and localize to the
paranodal axolemma in myelinated fibers of the peripheral nervous
system and CNS (10, 31). It has been suggested that RPTP
is expressed in oligodendrocyte paranodal loops and can interact with
the Caspr-contactin complex at the surface of the axon. RPTP
may
therefore participate in formation of the paranode. However, we did not
detect ultrastructural abnormalities in the paranodes of
RPTP
/
animals.
RPTP

is largely expressed in glial cells. There is also growing
evidence that RPTPs may play a major role in glial differentiation
because most RPTPs are expressed in oligodendrocytes and regulated
during the process of maturation of oligodendrocytes (
36).
Expression
of RPTP

is regulated during gliogenesis (
6).
We could not
detect any differences by light microscopy. However,
analysis
by electron microscopy revealed that RPTP

/
sheaths are normal in appearance but display abnormalities in
the
thicker sheaths, suggesting a greater susceptibility to deformation
and
disintegration as well as more cytoplasm-containing lamellae
in regions
that are normally compact. The results suggest that
the
RPTP

/
myelin may be less stable than normal
myelin.
Abnormalities of this kind have been seen in mutants deficient in
myelin glycolipids (
9), myelin basic protein
(
15),
or proteolipid protein (
16,
39). The
findings for RPTP

/
mice thus could reflect
abnormalities in the proportions of myelin
constituents. In addition,
we cannot rule out the possibility
that the RPTP

/
oligodendrocytes are defective and that the myelin abnormalities
seen
are secondary to the oligodendrocyte
defects.
The results presented here provide evidence regarding the role of
RPTP

in the adult mouse. The fact that the loss of the
three
isoforms of RPTP

does not grossly affect any of the processes
tested
raises questions about several proposed roles of RPTP
in neurite
outgrowth, cell migration, axon guidance, and gliogenesis.
Our data
suggest that RPTP

is not necessary for any of these
events and/or
that the loss of RPTP

may be compensated for by
other PTPs expressed
in the nervous
system.
 |
ACKNOWLEDGMENTS |
We thank the personnel, in particular Anna Auerbach, of the NYU
Medical Center Transgenic/ES Cell Chimera facility.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pharmacology, New York University Medical Center, 550 First Ave., New York, NY 10016. Phone: (212) 263-7111. Fax: (212) 263-7133. E-mail: Schlej01{at}popmail.med.nyu.edu.
 |
REFERENCES |
| 1.
|
Amaral, D. G., and P. W. Menno.
1995.
Hippocampal formation, p. 443-493.
In
G. Paxinos (ed.), The rat nervous system. Academic Press, San Diego, Calif.
|
| 2.
|
Barnea, G.,
M. Grumet,
P. Milev,
O. Silvennoinen,
J. B. Levy,
J. Sap, and J. Schlessinger.
1994.
Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin.
J. Biol. Chem.
269:14349-14352[Abstract/Free Full Text].
|
| 3.
|
Barnea, G.,
O. Silvennoinen,
B. Shaanan,
A. M. Honegger,
P. D. Canoll,
P. D'Eustachio,
B. Morse,
J. B. Levy,
S. Laforgia,
K. Huebner, et al.
1993.
Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases.
Mol. Cell. Biol.
13:1497-1506[Abstract/Free Full Text].
|
| 4.
|
Brady-Kalnay, S. M., and N. K. Tonks.
1995.
Protein tyrosine phosphatases as adhesion receptors.
Curr. Opin. Cell Biol.
7:650-657[CrossRef][Medline].
|
| 5.
|
Canoll, P. D.,
G. Barnea,
J. B. Levy,
J. Sap,
M. Ehrlich,
O. Silvennoinen,
J. Schlessinger, and J. M. Musacchio.
1993.
The expression of a novel receptor-type tyrosine phosphatase suggests a role in morphogenesis and plasticity of the nervous system.
Brain Res. Dev. Brain Res.
75:293-298[CrossRef][Medline].
|
| 6.
|
Canoll, P. D.,
S. Petanceska,
J. Schlessinger, and J. M. Musacchio.
1996.
Three forms of RPTP-beta are differentially expressed during gliogenesis in the developing rat brain and during glial cell differentiation in culture.
J. Neurosci. Res.
44:199-215[CrossRef][Medline].
|
| 7.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 8.
|
Clement, A. M.,
S. Nadanaka,
K. Masayama,
C. Mandl,
K. Sugahara, and A. Faissner.
1998.
The DSD-1 carbohydrate epitope depends on sulfation, correlates with chondroitin sulfate D motifs, and is sufficient to promote neurite outgrowth.
J. Biol. Chem.
273:28444-28453[Abstract/Free Full Text].
|
| 9.
|
Coetzee, T.,
N. Fujita,
J. Dupree,
R. Shi,
A. Blight,
K. Suzuki,
K. Suzuki, and B. Popko.
1996.
Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability.
Cell
86:209-219[CrossRef][Medline].
|
| 10.
|
Einheber, S.,
G. Zanazzi,
W. Ching,
S. Scherer,
T. A. Milner,
E. Peles, and J. L. Salzer.
1997.
The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination.
J. Cell Biol.
139:1495-1506[Abstract/Free Full Text].
|
| 11.
|
Faissner, A.,
A. Clement,
A. Lochter,
A. Streit,
C. Mandl, and M. Schachner.
1994.
Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties.
J. Cell Biol.
126:783-799[Abstract/Free Full Text].
|
| 12.
|
Fawcett, J. W., and R. A. Asher.
1999.
The glial scar and central nervous system repair.
Brain Res. Bull.
49:377-391[CrossRef][Medline].
|
| 13.
|
Friedlander, D. R.,
P. Milev,
L. Karthikeyan,
R. K. Margolis,
R. U. Margolis, and M. Grumet.
1994.
The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth.
J. Cell Biol.
125:669-680[Abstract/Free Full Text].
|
| 14.
|
Garwood, J.,
O. Schnadelbach,
A. Clement,
K. Schutte,
A. Bach, and A. Faissner.
1999.
DSD-1-proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage.
J. Neurosci.
19:3888-3899[Abstract/Free Full Text].
|
| 15.
|
Gould, R. M.,
A. L. Byrd, and E. Barbarese.
1995.
The number of Schmidt-Lanterman incisures is more than doubled in shiverer PNS myelin sheaths.
J. Neurocytol.
24:85-98[CrossRef][Medline].
|
| 16.
|
Griffiths, I.,
M. Klugmann,
T. Anderson,
D. Yool,
C. Thomson,
M. H. Schwab,
A. Schneider,
F. Zimmermann,
M. McCulloch,
N. Nadon, and K. A. Nave.
1998.
Axonal swellings and degeneration in mice lacking the major proteolipid of myelin.
Science
280:1610-1613[Abstract/Free Full Text].
|
| 17.
|
Grumet, M.,
A. Flaccus, and R. U. Margolis.
1993.
Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules.
J. Cell Biol.
120:815-824[Abstract/Free Full Text].
|
| 18.
|
Grumet, M.,
P. Milev,
T. Sakurai,
L. Karthikeyan,
M. Bourdon,
R. K. Margolis, and R. U. Margolis.
1994.
Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue.
J. Biol. Chem.
269:12142-12146[Abstract/Free Full Text].
|
| 19.
|
Haug, F.-M. S.
1973.
Heavy metals in the brain. A light microscopic study in the rat with Timm's sulphide silver method: methodological considerations and cytological and regional staining patterns.
Adv. Anat. Embryol. Cell Biol.
47:1-71[Medline].
|
| 20.
|
Haunso, A.,
M. R. Celio,
R. K. Margolis, and P. A. Menoud.
1999.
Phosphacan immunoreactivity is associated with perineuronal nets around parvalbumin-expressing neurones.
Brain Res.
834:219-222[CrossRef][Medline].
|
| 21.
|
Holland, S. J.,
E. Peles,
T. Pawson, and J. Schlessinger.
1998.
Cell-contact-dependent signalling in axon growth and guidance: Eph receptor tyrosine kinases and receptor protein tyrosine phosphatase beta.
Curr. Opin. Neurobiol.
8:117-127[CrossRef][Medline].
|
| 22.
|
Katoh-Semba, R., and A. Oohira.
1993.
Core proteins of soluble chondroitin sulfate proteoglycans purified from the rat brain block the cell cycle of PC12D cells.
J. Cell. Physiol.
156:17-23[CrossRef][Medline].
|
| 23.
|
Kordeli, E.,
S. Lambert, and V. Bennett.
1995.
AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier.
J. Biol. Chem.
270:2352-2359[Abstract/Free Full Text].
|
| 24.
|
Krueger, N. X., and H. Saito.
1992.
A human transmembrane protein-tyrosine-phosphatase, PTP zeta, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases.
Proc. Natl. Acad. Sci. USA
89:7417-7421[Abstract/Free Full Text].
|
| 25.
|
Levy, J. B.,
P. D. Canoll,
O. Silvennoinen,
G. Barnea,
B. Morse,
A. M. Honegger,
J. T. Huang,
L. A. Cannizzaro,
S. H. Park,
T. Druck, et al.
1993.
The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system.
J. Biol. Chem.
268:10573-10581[Abstract/Free Full Text].
|
| 26.
|
Li, J.,
J. W. Tullai,
W. H. Yu, and S. R. Salton.
1998.
Regulated expression during development and following sciatic nerve injury of mRNAs encoding the receptor tyrosine phosphatase HPTPzeta/RPTPbeta.
Brain Res. Mol. Brain Res.
60:77-88[Medline].
|
| 27.
|
Maeda, N., and M. Noda.
1996.
6B4 proteoglycan/phosphacan is a repulsive substratum but promotes morphological differentiation of cortical neurons.
Development
122:647-658[Abstract].
|
| 28.
|
Maeda, N., and M. Noda.
1998.
Involvement of receptor-like protein tyrosine phosphatase zeta/RPTPbeta and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration.
J. Cell Biol.
142:203-216[Abstract/Free Full Text].
|
| 29.
|
Mansour, S. L.,
K. R. Thomas, and M. R. Capecchi.
1988.
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.
Nature
336:348-352[CrossRef][Medline].
|
| 30.
|
McKeon, R. J.,
M. J. Jurynec, and C. R. Buck.
1999.
The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.
J. Neurosci.
19:10778-10788[Abstract/Free Full Text].
|
| 31.
|
Menegoz, M.,
P. Gaspar,
M. Le Bert,
T. Galvez,
F. Burgaya,
C. Palfrey,
P. Ezan,
F. Arnos, and J. A. Girault.
1997.
Paranodin, a glycoprotein of neuronal paranodal membranes.
Neuron
19:319-331[CrossRef][Medline].
|
| 32.
|
Nishizuka, M.,
S. Ikeda,
Y. Arai,
N. Maeda, and M. Noda.
1996.
Cell surface-associated extracellular distribution of a neural proteoglycan, 6B4 proteoglycan/phosphacan, in the olfactory epithelium, olfactory nerve, and cells migrating along the olfactory nerve in chick embryos.
Neurosci. Res.
24:345-355[CrossRef][Medline].
|
| 33.
|
Ohyama, K.,
H. Kawano,
H. Asou,
T. Fukuda,
A. Oohira,
K. Uyemura, and K. Kawamura.
1998.
Coordinate expression of L1 and 6B4 proteoglycan/phosphacan is correlated with the migration of mesencephalic dopaminergic neurons in mice.
Brain Res. Dev. Brain Res.
107:219-226[CrossRef][Medline].
|
| 34.
|
Peles, E.,
M. Nativ,
P. L. Campbell,
T. Sakurai,
R. Martinez,
S. Lev,
D. O. Clary,
J. Schilling,
G. Barnea,
G. D. Plowman, et al.
1995.
The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin.
Cell
82:251-260[CrossRef][Medline].
|
| 35.
|
Peles, E.,
M. Nativ,
M. Lustig,
M. Grumet,
J. Schilling,
R. Martinez,
G. D. Plowman, and J. Schlessinger.
1997.
Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions.
EMBO J.
16:978-988[CrossRef][Medline].
|
| 36.
|
Ranjan, M., and L. D. Hudson.
1996.
Regulation of tyrosine phosphorylation and protein tyrosine phosphatases during oligodendrocyte differentiation.
Mol. Cell Neurosci.
7:404-418[CrossRef][Medline].
|
| 37.
|
Rasband, M. N.,
E. Peles,
J. S. Trimmer,
S. R. Levinson,
S. E. Lux, and P. Shrager.
1999.
Dependence of nodal sodium channel clustering on paranodal axoglial contact in the developing CNS.
J. Neurosci.
19:7516-7528[Abstract/Free Full Text].
|
| 38.
|
Rosenbluth, J.
1966.
Redundant myelin sheaths and other ultrastructural features of the toad cerebellum.
J. Cell Biol.
28:73-93[Abstract/Free Full Text].
|
| 39.
|
Rosenbluth, J.,
W. Stoffel, and R. Schiff.
1996.
Myelin structure in proteolipid protein (PLP)-null mouse spinal cord.
J. Comp. Neurol.
371:336-344[CrossRef][Medline].
|
| 40.
|
Sakurai, T.,
M. Lustig,
M. Nativ,
J. J. Hemperly,
J. Schlessinger,
E. Peles, and M. Grumet.
1997.
Induction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase beta.
J. Cell Biol.
136:907-918[Abstract/Free Full Text].
|
| 41.
|
Shintani, T.,
E. Watanabe,
N. Maeda, and M. Noda.
1998.
Neurons as well as astrocytes express proteoglycan-type protein tyrosine phosphatase zeta/RPTPbeta: analysis of mice in which the PTPzeta/RPTPbeta gene was replaced with the LacZ gene.
Neurosci. Lett.
247:135-138[CrossRef][Medline].
|
| 42.
|
Soriano, P.,
C. Montgomery,
R. Geske, and A. Bradley.
1991.
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.
Cell
64:693-702[CrossRef][Medline].
|
| 43.
|
Stoker, A., and R. Dutta.
1998.
Protein tyrosine phosphatases and neural development.
Bioessays
20:463-472[CrossRef][Medline].
|
Molecular and Cellular Biology, October 2000, p. 7706-7715, Vol. 20, No. 20
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, P.-S., Wang, J., Xiao, Z.-C., Pallen, C. J.
(2009). Protein-tyrosine Phosphatase {alpha} Acts as an Upstream Regulator of Fyn Signaling to Promote Oligodendrocyte Differentiation and Myelination. J. Biol. Chem.
284: 33692-33702
[Abstract]
[Full Text]
-
Devaux, J., Gow, A.
(2008). Tight junctions potentiate the insulative properties of small CNS myelinated axons. JCB
183: 909-921
[Abstract]
[Full Text]
-
Chow, J. P. H., Fujikawa, A., Shimizu, H., Suzuki, R., Noda, M.
(2008). Metalloproteinase- and {gamma}-Secretase-mediated Cleavage of Protein-tyrosine Phosphatase Receptor Type Z. J. Biol. Chem.
283: 30879-30889
[Abstract]
[Full Text]
-
Fukazawa, N., Yokoyama, S., Eiraku, M., Kengaku, M., Maeda, N.
(2008). Receptor Type Protein Tyrosine Phosphatase {zeta}-Pleiotrophin Signaling Controls Endocytic Trafficking of DNER That Regulates Neuritogenesis. Mol. Cell. Biol.
28: 4494-4506
[Abstract]
[Full Text]
-
Kudo, T., Fujii, T., Ikegami, S., Inokuchi, K., Takayama, Y., Ikehara, Y., Nishihara, S., Togayachi, A., Takahashi, S., Tachibana, K., Yuasa, S., Narimatsu, H.
(2007). Mice lacking {alpha}1,3-fucosyltransferase IX demonstrate disappearance of Lewis x structure in brain and increased anxiety-like behaviors. Glycobiology
17: 1-9
[Abstract]
[Full Text]
-
Lamprianou, S., Vacaresse, N., Suzuki, Y., Meziane, H., Buxbaum, J. D., Schlessinger, J., Harroch, S.
(2006). Receptor Protein Tyrosine Phosphatase {gamma} Is a Marker for Pyramidal Cells and Sensory Neurons in the Nervous System and Is Not Necessary for Normal Development.. Mol. Cell. Biol.
26: 5106-5119
[Abstract]
[Full Text]
-
Foehr, E. D., Lorente, G., Kuo, J., Ram, R., Nikolich, K., Urfer, R.
(2006). Targeting of the Receptor Protein Tyrosine Phosphatase {beta} with a Monoclonal Antibody Delays Tumor Growth in a Glioblastoma Model. Cancer Res.
66: 2271-2278
[Abstract]
[Full Text]
-
Berset, T. A., Hoier, E. F., Hajnal, A.
(2005). The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions. Genes Dev.
19: 1328-1340
[Abstract]
[Full Text]
-
Niisato, K., Fujikawa, A., Komai, S., Shintani, T., Watanabe, E., Sakaguchi, G., Katsuura, G., Manabe, T., Noda, M.
(2005). Age-Dependent Enhancement of Hippocampal Long-Term Potentiation and Impairment of Spatial Learning through the Rho-Associated Kinase Pathway in Protein Tyrosine Phosphatase Receptor Type Z-Deficient Mice. J. Neurosci.
25: 1081-1088
[Abstract]
[Full Text]
-
Yahiro, K., Wada, A., Yamasaki, E., Nakayama, M., Nishi, Y., Hisatsune, J., Morinaga, N., Sap, J., Noda, M., Moss, J., Hirayama, T.
(2004). Essential Domain of Receptor Tyrosine Phosphatase {beta} (RPTP{beta}) for Interaction with Helicobacter pylori Vacuolating Cytotoxin. J. Biol. Chem.
279: 51013-51021
[Abstract]
[Full Text]
-
Garwood, J., Heck, N., Reichardt, F., Faissner, A.
(2003). Phosphacan Short Isoform, a Novel Non-proteoglycan Variant of Phosphacan/Receptor Protein Tyrosine Phosphatase-{beta}, Interacts with Neuronal Receptors and Promotes Neurite Outgrowth. J. Biol. Chem.
278: 24164-24173
[Abstract]
[Full Text]
-
Tanaka, M., Maeda, N., Noda, M., Marunouchi, T.
(2003). A Chondroitin Sulfate Proteoglycan PTPzeta /RPTPbeta Regulates the Morphogenesis of Purkinje Cell Dendrites in the Developing Cerebellum. J. Neurosci.
23: 2804-2814
[Abstract]
[Full Text]
-
Stoica, G. E., Kuo, A., Powers, C., Bowden, E. T., Sale, E. B., Riegel, A. T., Wellstein, A.
(2002). Midkine Binds to Anaplastic Lymphoma Kinase (ALK) and Acts as a Growth Factor for Different Cell Types. J. Biol. Chem.
277: 35990-35998
[Abstract]
[Full Text]
-
Carothers, A. M., Melstrom, K. A. Jr., Mueller, J. D., Weyant, M. J., Bertagnolli, M. M.
(2001). Progressive Changes in Adherens Junction Structure during Intestinal Adenoma Formation in Apc Mutant Mice. J. Biol. Chem.
276: 39094-39102
[Abstract]
[Full Text]
-
Stepanek, L., Sun, Q. L., Wang, J., Wang, C., Bixby, J. L.
(2001). CRYP-2/cPTPRO is a neurite inhibitory repulsive guidance cue for retinal neurons in vitro. JCB
154: 867-878
[Abstract]
[Full Text]